Cargando…
Efficacy and safety evaluation of fludarabine-based chemotherapy regimen for patients with non-Hodgkin lymphoma: A meta-analysis
This meta-analysis was performed to evaluate the efficacy and safety of fludarabine (F)-based regimen for the treatment of non-Hodgkin lymphoma (NHL) compared with other regimens with no F contained. PubMed, Embase, Cochrane Library, Wanfang, VIP, and CNKI databases were searched to identify eligibl...
Autores principales: | Zhang, Xiaoping, Ge, Zheng, Chen, Baoan, Liu, Ran, Gao, Chong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571700/ https://www.ncbi.nlm.nih.gov/pubmed/28816963 http://dx.doi.org/10.1097/MD.0000000000007781 |
Ejemplares similares
-
Efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating non-Hodgkin lymphoma: A systematic review and meta-analysis of clinical trials
por: Guan, Jiaheng, et al.
Publicado: (2022) -
Busulfan and Fludarabine Conditioning Regimen Given at Hematological Nadir of Cytoreduction Fludarabine, Cytarabine, and Idarubicin Chemotherapy in Patients With Refractory Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation: A Single Arm Pilot Consort Study
por: Tang, Wei, et al.
Publicado: (2015) -
Model-based meta-analysis of progression-free survival in non-Hodgkin lymphoma patients
por: Li, Mengyao, et al.
Publicado: (2017) -
Prevalence of Common Non-Hodgkin Lymphomas and Subtypes of Hodgkin Lymphoma by Nodal Site of Involvement: A Systematic Retrospective Review of 938 Cases
por: Laurent, Camille, et al.
Publicado: (2015) -
Prognostic significance of latent membrane protein 1 expression in non-Hodgkin lymphoma: A meta-analysis
por: Li, Xiao-Mei, et al.
Publicado: (2017)